As the number of new hepatitis C virus infections continues to rise in the United States, rapid diagnosis and treatment of high-risk patients is more important than ever. In this Q&A, Benjamin Eckhardt, MD, answered our questions about his study on this topic at IDWeek 2021.
In this "Test Your Knowledge" quiz, Daniel S Fierer, MD, asks you about a new patient with Hepatitis C, and her eligibility for a simplified treatment regimen.
In this commentary, Raymond Chung, MD, from Massachusetts General Hospital, explains why it is key to stage a patient’s disease after an HCV diagnosis—and how to do it.
A recent survey of individuals with hepatitis C who inject drugs aimed to highlight the nonclinical impacts of HCV treatment. Have your patients in this population experienced improvements in quality of life? Let us know by taking our poll.